A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Public ClinicalTrials.gov record NCT07310420. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 1 Single-arm, Open-label, Multicenter Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in 2 Parallel Cohorts of Premenopausal Women With Early-stage and Advanced Hormone Receptor-positive (HR+) Breast Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this trial is to evaluate ovarian suppression following treatment with ZOLADEX 10.8 mg by luteinizing hormone (LH) within each cohort.
Study identification
- NCT ID
- NCT07310420
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 176 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 29, 2026
- Primary completion
- Mar 29, 2027
- Completion
- Jul 30, 2027
- Last update posted
- Sep 8, 2026
2026 – 2027
United States locations
- U.S. sites
- 23
- U.S. states
- 13
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Genesis Cancer and Blood Institute | Hot Springs | Arkansas | 71913 | Recruiting |
| MedStar Heart & Vascular Institute (MHVI) - MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | Recruiting |
| Cancer Centers of Florida | Ocoee | Florida | 34761 | Recruiting |
| University Cancer & Blood Center, LLC | Athens | Georgia | 30607 | Recruiting |
| Summit Cancer Care | Savannah | Georgia | 31405 | Recruiting |
| NorthShore University Health System - Evanston Hospital | Evanston | Illinois | 60201 | Recruiting |
| NorthShore University HealthSystem - Evanston Hospital | Evanston | Illinois | 60201 | Recruiting |
| Duly Health and Care | Lisle | Illinois | 60532 | Recruiting |
| Orchard Healthcare Research | Skokie | Illinois | 60077 | Recruiting |
| Springfield Clinic - The Cancer Center | Springfield | Illinois | 62702 | Recruiting |
| Ochsner Medical Center (OMC) | New Orleans | Louisiana | 70121 | Recruiting |
| Profound Research LLC at Michigan Hematology and Oncology Consultants | Royal Oak | Michigan | 48073 | Recruiting |
| St. Vincent Frontier Cancer Center (SVFCC) - Billings (Frontier Cancer Center and Blood Institute) | Billings | Montana | 59102-6746 | Recruiting |
| San Juan Oncology Associates | Farmington | New Mexico | 87401 | Recruiting |
| New York Oncology Hematology - Amsterdam Cancer Center | Amsterdam | New York | 12010 | Recruiting |
| Chelsea Medical Center at Mount Sinai | New York | New York | 10011 | Recruiting |
| Montefiore Medical Center | The Bronx | New York | 10467 | Recruiting |
| Clinical Research Alliance Inc | Westbury | New York | 11590 | Recruiting |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | Recruiting |
| The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc. | Columbus | Ohio | 43219 | Recruiting |
| St. Luke's University Health Network | Bethlehem | Pennsylvania | 18015 | Recruiting |
| Guthrie Medical Group | Sayre | Pennsylvania | 18840 | Recruiting |
| Oncology Consultants PA | Houston | Texas | 77030 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07310420, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 8, 2026 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07310420 live on ClinicalTrials.gov.